Sakamaki, Akira

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis. [electronic resource] - Internal medicine (Tokyo, Japan) Aug 2020 - 1849-1853 p. digital

Publication Type: Case Reports; Journal Article

1349-7235

10.2169/internalmedicine.4593-20 doi


Aged
Amino Acids, Branched-Chain--adverse effects
Anti-Bacterial Agents--therapeutic use
Blind Loop Syndrome--chemically induced
Breath Tests--methods
Hepatic Encephalopathy--drug therapy
Humans
Lactulose--adverse effects
Liver Cirrhosis, Alcoholic--complications
Male
Rifaximin--therapeutic use